URGN stock

UroGen Pharma Ltd (URGN) operating margin is -39.8%

UroGen Pharma Ltd (URGN) operating margin is -39.8% as of 2024-12-31. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.

Read the full URGN research page for quote, filings, and the rest of the model. This satellite exists so “UroGen Pharma Ltd operating margin” can rank with the actual number, then send you to /stock/urgn.

Full URGN analysis